Intestinal Metaplasia Clinical Trial
Official title:
Sensitivity of Targeted Biopsy Within Sydney Protocol by Using Narrow Band Imaging for Extensive Gastric Intestinal Metaplasia Diagnosis
Sensitivity of Targeted Biopsy Within Sydney Protocol by Using Narrow Band Imaging for Extensive Gastric Intestinal Metaplasia Diagnosis Objective: The aim of this study is to evaluate the sensitivity of targeted biopsy within Sydney protocol by using narrow band imaging for Extensive Gastric Intestinal Metaplasia diagnosis Research design: Diagnosis study Sample size: 105 cases Data analysis: The outcomes will be presented using 2 by 2 tables and if the data are normal distribution the categorical data will be analysed using McNemar's test
Status | Recruiting |
Enrollment | 105 |
Est. completion date | October 31, 2021 |
Est. primary completion date | July 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - At least 18 year of age - Suspected GIM by previous tissue pathology - Able to provide informed consent for participation Exclusion Criteria: - Previous gastric surgery including gastrectomy and bypass surgery - Coagulopathy - Pregnancy - Active upper GI bleeding |
Country | Name | City | State |
---|---|---|---|
Thailand | King Chulalongkorn Memorial Hospital | Bangkok |
Lead Sponsor | Collaborator |
---|---|
King Chulalongkorn Memorial Hospital |
Thailand,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sensitivity of targeted biopsy within Sydney protocol by using narrow band imaging for Extensive Gastric Intestinal Metaplasia diagnosis | Sensitivity of targeted biopsy within Sydney protocol by using narrow band imaging for Extensive Gastric Intestinal Metaplasia diagnosis | 4 weeks after completing the enrollment. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03554356 -
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
|
N/A | |
Recruiting |
NCT01398579 -
Comparison Between Probe-based Confocal Laser Endomicroscopy, White-light Endoscopy and Virtual Chromoendoscopy
|
Phase 1 | |
Completed |
NCT01614418 -
Radiofrequency Ablation for Gastric Metaplasia and Dysplasia
|
Phase 1/Phase 2 | |
Completed |
NCT06282484 -
A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous Lesions
|
||
Not yet recruiting |
NCT06085677 -
The Gastric HormonE BioMarkers of Preneoplastic Lesions Study
|
||
Completed |
NCT01024621 -
Confocal Laser Endomicroscopy for the Detection of Gastric Intestinal Metaplasia: a Randomized Controlled Trial
|
N/A | |
Terminated |
NCT05579444 -
Systems Biology of Gastrointestinal and Related Diseases
|
||
Completed |
NCT03188406 -
Gastric Cancer Precursor Lesions (GCPL) Study
|
||
Recruiting |
NCT05053945 -
Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
|
||
Completed |
NCT02075905 -
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
|
N/A | |
Completed |
NCT01374074 -
Racial Disparity in Barrett's Esophagus
|
N/A | |
Recruiting |
NCT02457624 -
Gastric Cancer Screening Quality Improvement System Establishment
|
N/A | |
Recruiting |
NCT05818072 -
The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE
|
N/A | |
Completed |
NCT04296513 -
Diagnosis of Gastritis, H. Pylori Infection and Atrophic Gastritis in Dyspeptic Patients
|
||
Completed |
NCT01896310 -
New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy
|
N/A | |
Completed |
NCT01373125 -
Is the Neosquamous Epithelium "Normal" Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?
|
N/A | |
Completed |
NCT03976739 -
Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Cross-sectional Study.
|
||
Recruiting |
NCT04054713 -
Acetic Acid for the Detection of Esophageal Neoplasms
|
N/A | |
Terminated |
NCT02788214 -
Helicobacter Pylori Genome Project (HpGP)
|
||
Enrolling by invitation |
NCT03228095 -
Volatiles in Breath and Headspace Analysis - Diagnostic Markers
|